Digital Biomanufacturing Market Report 2026
Digital Biomanufacturing Market Report 2026
Global Outlook – By Type (Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types), By Types Of Biologic(s) Manufactured (Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types), By Technology (AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies), By Application (BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications), By End User (Biopharmaceutical Companies, Academic And Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2035
Digital Biomanufacturing Market Overview
• Digital Biomanufacturing market size has reached to $23.97 billion in 2025 • Expected to grow to $46.02 billion in 2030 at a compound annual growth rate (CAGR) of 14% • Growth Driver: Increased Efficiency And Productivity Fuel The Growth Of Digital Biomanufacturing In A Global Context • Market Trend: Advancements Supporting SMEs And Startups In Biomanufacturing • North America was the largest region in 2025.
What Is Covered Under Digital Biomanufacturing Market?
Digital biomanufacturing is the use of digital technologies and advanced analytics in the field of biomanufacturing. It blends data-driven decision-making, automation, and sophisticated manufacturing technology to increase process efficiency and expedite innovation in the biomanufacturing business. The main types of digital biomanufacturing are manufacturing technologies, analytical and process control technologies, software, and others. Manufacturing technology refers to techniques and processes that aim to improve manufacturing quality, productivity, and practices and these technologies aid in the enhancement of process efficiency, product quality, and scalability in the manufacture of biological products. Major types of biologic(s) manufactured are antibodies, cell and gene therapies, proteins, vaccines, and others using various technologies such as AI and IoMT solutions, process analytical technologies, data analytics software, predictive analytics and digital twin technologies, and others that are applied in bioprocess optimization, biomanufacturing process automation and control, and others by the different end users such as biopharmaceutical companies, and academic and research institutes.
What Is The Digital Biomanufacturing Market Size and Share 2026?
The digital biomanufacturing market size has grown rapidly in recent years. It will grow from $23.97 billion in 2025 to $27.25 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to growth of biologics production, need for process efficiency, adoption of automation in pharma manufacturing, regulatory focus on quality compliance, increasing manufacturing complexity.What Is The Digital Biomanufacturing Market Growth Forecast?
The digital biomanufacturing market size is expected to see rapid growth in the next few years. It will grow to $46.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to expansion of cell and gene therapies, adoption of continuous manufacturing, integration of AI in bioprocessing, demand for faster time to market, investment in smart biomanufacturing facilities. Major trends in the forecast period include data driven bioprocess optimization, automation of biomanufacturing operations, digital twin adoption, real time process monitoring, AI enabled quality control.Global Digital Biomanufacturing Market Segmentation
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types 2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types 3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies 4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications 5) By End User: Biopharmaceutical Companies, Academic And Research Institutes Subsegments: 1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies 2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools 3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software 4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For BiomanufacturingWhat Is The Driver Of The Digital Biomanufacturing Market?
The growing pharmaceutical industry is expected to drive the growth in digital biomanufacturing going forward. The pharmaceutical industry refers to the sector involved in the research, development, and production of medicines while playing a critical role in healthcare by ensuring the availability of safe and effective treatments. The growing pharmaceutical industry is rising due to increasing global demand for healthcare and medications driven by a larger and aging population, fueling higher production and innovation in drug development to meet expanding medical needs. Digital biomanufacturing helps the pharmaceutical industry by integrating advanced data analytics, automation, and real-time monitoring to optimize drug production, improve quality control, reduce manufacturing costs, and accelerate the development of safe and effective therapies. For instance, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association and lobbying organization, in 2024 North America accounted for 54.8% of estimated world pharmaceutical sales compared with 22.7% for Europe. In 2024 it invested an estimated €55,000 million in R&D in Europe. Therefore, the growing pharmaceutical industry is driving the digital biomanufacturing industry.Key Players In The Global Digital Biomanufacturing Market
Major companies operating in the digital biomanufacturing market are Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbHGlobal Digital Biomanufacturing Market Trends and Insights
Major companies operating in the digital biomanufacturing market are focusing on developing innovative technologies such as single use bioreactors to enhance process efficiency, scalability, and flexibility in biologics production. Single-use bioreactors refer to a type of bioreactor designed for single-use applications in biomanufacturing, eliminating the need for cleaning and sterilization between batches while offering flexibility, reducing contamination risks, and streamlining the production of biologics and vaccines. For instance, in March 2025, European Commission, a Belgium based government agency, launched the Biotech and Biomanufacturing Hub, a dedicated online platform to support biotech and biomanufacturing companies across the EU, especially startups and SMEs, providing one stop access to funding programmes, regulatory guidance, intellectual property support, pilot and testing infrastructure, and networking tools, while also serving as a key part of the Commission’s “Boosting Biotechnology and Biomanufacturing in the EU” strategy aimed at strengthening Europe’s biotech ecosystem, increasing competitiveness, reducing dependence on external supply chains, and streamlining the journey from innovation to commercialisation for biotech-based products.What Are Latest Mergers And Acquisitions In The Digital Biomanufacturing Market?
In December 2023, Danaher Corporation, a U.S.-based science and technology company, acquired Abcam plc for an undisclosed amount. Through this acquisition, Danaher Corporation aims to strengthen its life sciences portfolio by integrating Abcam plc’s expertise in high-quality antibodies and reagents, enhancing its research and diagnostic capabilities, and expanding its global reach in the biotechnology and pharmaceutical markets. Abcam plc is a UK-based biotechnology and life sciences company that provides digital biomanufacturing.Regional Insights
North America was the largest region in the digital biomanufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Digital Biomanufacturing Market?
The digital biomanufacturing market consists of revenues earned by entities by providing various technologies that support the manufacturing of biologics such as big data, cloud computing, lean product and process development, sensor technologies, process control, and enterprise control. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital biomanufacturing market also includes sales of sensors, analyzers, and actuators and process control systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Digital Biomanufacturing Market Report 2026?
The digital biomanufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital biomanufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Digital Biomanufacturing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $27.25 billion |
| Revenue Forecast In 2035 | $46.02 billion |
| Growth Rate | CAGR of 13.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Types Of Biologic(s) Manufactured, Technology, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Digital Biomanufacturing Market Report 2026 market was valued at $23.97 billion in 2025, increased to $27.25 billion in 2026, and is projected to reach $46.02 billion by 2030.
request a sample hereThe expected CAGR for the Digital Biomanufacturing Market Report 2026 market during the forecast period 2025–2030 is 14.0%.
request a sample hereMajor growth driver of the market includes: Increased Efficiency And Productivity Fuel The Growth Of Digital Biomanufacturing In A Global Context in the Digital Biomanufacturing Market Report 2026 market. For further insights on this market,
request a sample hereThe digital biomanufacturing market covered in this report is segmented –
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing
request a sample here1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing
Major trend in this market includes: Advancements Supporting SMEs And Startups In Biomanufacturing For further insights on this market,
request a sample hereMajor companies operating in the Digital Biomanufacturing Market Report 2026 market are Major companies operating in the digital biomanufacturing market are Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbH
request a sample hereNorth America was the largest region in the digital biomanufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here